Active Ingredient History
Pentastarch is a subgroup of hydroxyethyl starch, with five hydroxyethyl groups out of each 11 hydroxyls, giving it approximately 50% hydroxyethylation. This compares with tetrastarch at 40% and hetastarch at 70% hydroxyethylation, respectively. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Lung Injury (Phase 3)
Aged (Phase 4)
Anesthesia (Phase 4)
Anesthesia, Epidural (Phase 4)
Anesthesia, Obstetrical (Phase 4)
Anesthesia, Spinal (Phase 4)
Angina Pectoris (Phase 2)
Angina, Unstable (Phase 2)
Arthroplasty, Replacement, Hip (Phase 4)
Blood Coagulation (Phase 4)
Blood Loss, Surgical (Phase 4)
Blood Pressure (Phase 3)
Body Fluids (Phase 4)
Brain Diseases (Phase 2)
Breast Diseases (Phase 4)
Burns (Phase 4)
Cardiopulmonary Bypass (Phase 4)
Cesarean Section (Phase 4)
Chronic Limb-Threatening Ischemia (Phase 2)
Colitis, Ulcerative (Phase 3)
Colonic Neoplasms (Phase 3)
Colonic Polyps (Phase 3)
Colorectal Surgery (Phase 4)
Coronary Artery Bypass (Phase 4)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Critical Care (Phase 3)
Crohn Disease (Phase 3)
Cystic Fibrosis (Phase 2)
Diverticulitis (Phase 3)
Edema (Phase 2)
Excipients ()
Extracorporeal Circulation (Phase 3)
Fertilization in Vitro (Early Phase 1)
Fluid Therapy (Phase 4)
General Surgery (Phase 4)
Healthy Volunteers (Phase 1)
Heart Valve Diseases (Phase 3)
Hemorrhage (Phase 4)
Hemostasis (Phase 4)
Hip Fractures (Phase 3)
HIV (Phase 1)
HIV Infections (Phase 1)
Hypotension (Phase 4)
Hypovolemia (Phase 3)
Intestinal Polyps (Phase 3)
Intra-Abdominal Hypertension (Phase 4)
Intraoperative Complications (Phase 4)
Ischemia (Phase 3)
Kidney Neoplasms (Phase 4)
Myocardial Infarction (Phase 2)
Organ Dysfunction Scores (Early Phase 1)
Osteoarthritis (Phase 4)
Ovarian Diseases (Early Phase 1)
Pancreatic Neoplasms (Phase 4)
Pancreaticoduodenectomy (Phase 3)
Parturition (Phase 4)
Peripheral Vascular Diseases (Phase 2)
Plasma (Phase 4)
Polyps (Phase 4)
Postoperative Complications (Phase 4)
Postoperative Hemorrhage (Phase 3)
Prostatic Neoplasms (Phase 4)
Pulmonary Edema (Early Phase 1)
Rectal Neoplasms (Phase 3)
Rectum (Phase 1)
Renal Insufficiency (Phase 4)
Respiratory Distress Syndrome (Phase 3)
Risk Factors (Phase 1)
Sepsis (Phase 4)
Shock, Septic (Phase 4)
Subarachnoid Hemorrhage (Phase 4)
Thoracic Surgery (Phase 4)
Thyroidectomy (Phase 4)
Traumatology (Phase 4)
Tuberculosis (Early Phase 1)
Urologic Surgical Procedures (Phase 4)
Vascular Diseases (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue